Did U.K. and Canadian Authorizations of Pfizer's COVID Vaccine Pressure the U.S.?
On Dec. 12, 2020, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to BNT162b2, the COVID-19 vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) after a positive recommendation from an advisory committee. This U.S. EUA followed similar moves made by the governments of Canada and the United Kingdom. In this Motley Fool Live video recorded on Dec. 11, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Keith Speights discuss whether or not the U.K. and Canadian authorizations put pressure on the U.S. to follow suit with its own authorization of BNT162b2.
Source Fool.com
